| BHYIX | NCOIX | BHYIX / NCOIX | |
| Total Expense Ratio | 0.57 | 0.77 | 74% |
| Annual Report Gross Expense Ratio | 0.58 | 0.84 | 69% |
| Fund Existence | 28 years | 16 years | - |
| Gain YTD | 1.867 | 2.648 | 71% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 100000 | 2,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 27.3B | 568M | 4,806% |
| Annual Yield % from dividends | 6.66 | 7.43 | 90% |
| Returns for 1 year | 5.20 | 6.62 | 79% |
| Returns for 3 years | 27.62 | 29.51 | 94% |
| Returns for 5 years | 23.43 | 25.43 | 92% |
| Returns for 10 years | 73.11 | 72.04 | 101% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSGFX | 25.68 | 0.18 | +0.71% |
| Morgan Stanley Inst Global Franchise C | |||
| BRUHX | 19.05 | 0.07 | +0.37% |
| MFS Blended Research Value Equity I | |||
| SUFCX | 42.53 | 0.03 | +0.07% |
| NAA Mid Growth C | |||
| FSLZX | 54.87 | 0.04 | +0.07% |
| Fidelity Advisor Stock Selec Mid Cp Z | |||
| TAMVX | 38.28 | -0.13 | -0.34% |
| T. Rowe Price Mid-Cap Value Adv | |||